Abstract

DURAN-MORALES, María Angélica  and  ARIZA-PARRA, Edwin J. Cardiomyopathy peripartum: potentially deadly disease. Medicas UIS [online]. 2016, vol.29, n.2, pp.103-111. ISSN 0121-0319.  https://doi.org/10.18273/revmed.v29n2-2016009.

Introduction: peripartum cardiomyopathy is a clinical condition underestimated, leading to a forgotten it, with a delay in diagnosis and treatment and thus to high rates of morbidity and mortality entity. The diagnosis is based on clinical signs and symptoms, plus evidence of heart failure that develops during the last month of pregnancy and the first five months postpartum echocardiography evidenced a left ventricular dysfunction. Objective: a current review of the different components of the disease, from the epidemiology, etiology, pathophysiology, clinical advances in diagnosis and treatment. Searching methodology: a search was performed in multiple databases such as PubMed, Cochrane, Sciencedirect and academic Google; where 96 articles were found, 38 were selected ruling out several items that did not meet inclusion criteria. Results: the most current databases of information found was chosen, 55 articles were selected and classification, etiology, pathophysiology, diagnosis, treatment and prognosis were reviewed. Conclusions: peripartum cardiomyopathy remains a major medical diagnosis and treatment for all large multidisciplinary team challenge; there must be a suspicion diagnosis to initiate appropriate and timely treatment approach wherein a decrease in morbidity and mortality can be achieved for both mother and fetus. There are new developments for the treatment of surgically, that help improve the quality of life for women who are with subsequent heart failure. MÉD.UIS. 2016;29(2):103-11.

Keywords : Cardiomyopathy; Pregnancy Complications; Heart Failure; Prolactin; Diagnosis; Therapeutics.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )